Analyst Ratings for Rigel Pharmaceuticals (RIGL) [Buys]

RIGL Rating Summary

  |   Expand Research on RIGL
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
9/6/2012 Leerink Swann
» Updated 8/26/2013
New Coverage Outperform
(N/A)
5.00
(7.00)
9.89 1.83 -81.5% Details
9/29/2011 JPMorgan New Coverage Overweight
(N/A)
14.00
(N/A)
6.97 1.83 -73.74% Details